WELL Health Technologies Corp (WELL) — Capital Reinvestment Ratio
Latest as of September 2025:
0.26x
WELL Health Technologies Corp (WELL) has a Capital Reinvestment Ratio of 0.26x as of September 2025, meaning it reinvests 0% of its operating cash flow (CA$75.84 Million) in capital expenditures (CA$19.39 Million). See WELL free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.26x
Capex / Operating Cash Flow
Operating Cash Flow
CA$75.84 Million
CAD
Capital Expenditures
CA$19.39 Million
CAD
Data as of
Sep 2025
Most recent filing
WELL Health Technologies Corp Capital Reinvestment Ratio (2021–2024)
This chart tracks WELL Health Technologies Corp's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for WELL Health Technologies Corp (2021–2024)
Year-by-year Capital Reinvestment Ratio for WELL Health Technologies Corp from 2021 to 2024. For live market cap and broader valuation context, see market cap of WELL Health Technologies Corp.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.70x | CA$9.52 Million | CA$16.23 Million | ▲ +346.0% |
| 2023 | 0.38x | CA$66.44 Million | CA$25.38 Million | ▲ +356.7% |
| 2022 | 0.08x | CA$76.55 Million | CA$6.40 Million | ▼ -30.5% |
| 2021 | 0.12x | CA$22.27 Million | CA$2.68 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow